Latest News

VaxDesign Corporation Receives 2011 Companies to Watch Award

Release Date: January 10, 2011

VaxDesign Honored for Its Technology, Growth and Contribution to Florida's Economy

ORLANDO, Fla. Biotechnology research and development company VaxDesign Corporation has been recognized as one of fifty 2011 "Companies to Watch" by GrowFL, the Florida Economic Gardening Institute at the University of Central Florida and ACG Florida, in association with the Edward Lowe Foundation. The award recognizes privately held Florida businesses that employ up to 99 employees and have between $750,000 to $50 million in annual revenue or capital.

"We're extremely pleased and honored to be among the fifty companies chosen," said the head of the VaxDesign Campus William Warren, "We have always felt a strong commitment to Florida and our local community. We're fortunate to be able to provide jobs for central Floridians, while helping to build Florida's growing biotechnology business community. We're thankful for the support we've received and will continue to work hard to maintain a strong presence in Florida."

The fifty companies will be honored at an awards celebration on February 17 at the Rosen Shingle Creek Resort in Orlando.

About VaxDesign

VaxDesign's flagship technology, the MIMIC® System, helps predict the immune response of an individual or selected group to a drug candidate or vaccine candidate. VaxDesign is now a wholly-owned subsidiary of sanofi pasteur, the vaccines division of sanofi-aventis Group, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to improve the lives of everyone. As world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines, protecting against 20 infectious diseases.

News Archive

Release Date
January 10, 2011 VaxDesign Corporation Receives 2011 Companies to Watch Award
November 5, 2010 U.S. Department of Defense discusses how the MIMIC® System helps save lives
September 27, 2010 Sanofi Pasteur to Acquire VaxDesign, a U.S. biotechnology company
January 19, 2010 NIST Names VaxDesign Recipient of 3-Year, $1.49 Million Grant
November 25, 2009 2009 Chemical and Biological Defense Conference Gives VaxDesign "Outstanding Collaboration" Award
June 2, 2009 VaxDesign is Now on Twitter
May 27, 2009 VaxDesign CEO Makes the Case for the MIMIC® System
May 12, 2009 MIMIC® System Helps U.S. Department of Defense Assess Plague Vaccine Candidate
January 29, 2009 VaxDesign's MIMIC® System receives 2009 Governor's New Product Award
September 19, 2008 VaxDesign to Discuss Alternative Methods to Animal Experimentation at Sanofi Pasteur in October
March 28, 2008 TIME Magazine Profiles VaxDesign’s MIMIC® Technology
March 3, 2008 IAVI and VaxDesign Partner to Develop an AIDS Vaccine Clinical Trial in a Test Tube
October 27, 2007 TechJournal South Profiles VaxDesign
October 22, 2007 VaxDesign Receives Prestigious R&D 100 Award
October 1, 2007 BioWorld includes VaxDesign as one of the most innovative companies in biotechnology
September 19, 2007 VaxDesign Receives 2007 William C. Schwartz Industry Innovation Award
August 6, 2007 R&D Magazine Profiles VaxDesign
October 18, 2006 VaxDesign is Helping Central Florida "Break Out"
September 11, 2006 Orlando Sentinel Features VaxDesign
April 12, 2006 Newsweek/MSNBC Features VaxDesign
July 18, 2005 VaxDesign Signs Cooperative R&D Agreement with USAMRIID